President Donald Trump is launching a new government-run website that he says will let Americans buy medications at lower prices. The new website, called TrumpRx, is expected to launch in 2026 and will direct consumers to discounts on drugmakers’ online stores, including Pfizer’s, as reported earlier by The New York Times and NPR.
The Tuesday announcement comes as part of a deal that grants Pfizer a three-year reprieve from tariffs in exchange for investing in US-based manufacturing, according to the company’s press release. Pfizer also agreed to lower prices on the “majority” of the primary care drugs sold through state Medicaid programs, which it says could result in an average savings of 50 percent.
Details about the TrumpRx.gov site are still slim, but senior officials told NPR that it would lead users to pharmaceutical companies’ websites to place orders, and that only patients not using health insurance would be able to take advantage of the discounts. The New York Times reports that officials also said Trump has reached similar agreements with other drugmakers, without specifying which ones.
[Notigroup Newsroom in collaboration with other media outlets, with information from the following sources]
